Sex, drugs and gender roles: mapping the use of sex and gender based analysis in pharmaceutical policy research
Printer-friendly versionA study by researchers at the UBC Centre for Health Services and Policy Research that concluded that the practice of sex- and gender-based analysis has still not been “internalized” or “mainstreamed by the community of pharmaceutical policy researchers. The author’s state that “increased application of SGBA is, in most cases, not only appropriate for the topics under investigation, but well within the reach of today's pharmaceutical policy researchers.”
The Canadian Women's Health Network and the Centres of Excellence for Women's Health program are financially supported by Health Canada through the Women's Health Contribution Program. The views herein do not necessarily represent the official policy of Health Canada.